NIH-funded research R01 grant

How the brain's natural opioids in the midbrain influence motivation

Official title: Investigating non-canonical mechanisms of endogenous opioids on motivation in dorsal midbrain

Funded at Washington University · NIH-11301827 · Data updated 2026-11-12

This project looks at whether natural opioid chemicals in a part of the midbrain change motivation and mood to help people with low motivation or mood disorders.

More Motivation research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startMarch 9, 2023
Project endJanuary 31, 2028
Funding year2026
Award (this year)$523,855
NIH project number5R01MH132504-04
Project IDNIH-11301827 on NIH RePORTER

Who could benefit from this research

Could help

Adults with depression, low motivation, or other affective disorders would be the most relevant candidates for future trials or follow-up studies based on these findings.

Less likely to help

People without mood or motivation symptoms, or those seeking immediate clinical treatment, are unlikely to receive direct benefit from this basic research.

What this research studies

From a patient's perspective, researchers are mapping how the brain's own opioid signals in small dorsal midbrain regions affect motivated behaviors. They will combine animal experiments, targeted molecular tools (including CRISPR-Cas9 to reduce opioid peptides), neural recordings, and computational modeling to link specific circuits to behavior. Prior work shows nearby midbrain sites can both boost and suppress appetite and motivation, and this project aims to clarify those opposing roles. The long-term goal is to point toward new targets for treatments of mood and motivational problems.

Why it matters

Potential benefit: If successful, this work could reveal new brain targets for therapies that better restore motivation and mood in people with affective disorders.

How similar studies have gone: Previous animal studies and pilot experiments (including opioid microinjections and CRISPR-based knockdown) have shown midbrain opioid signals can alter appetite and motivation, but the specific non-canonical mechanisms here are relatively new.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Castro, Daniel Charles — Washington University
  • Study coordinator: Castro, Daniel Charles

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.